The first of two adequate, well-controlled, short-term efficacy studies of metadoxine in children with ADHD

Trial Profile

The first of two adequate, well-controlled, short-term efficacy studies of metadoxine in children with ADHD

Planning
Phase of Trial: Phase II

Latest Information Update: 30 Aug 2016

At a glance

  • Drugs Metadoxine (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 30 Aug 2016 According to Alcobra media release, this study is expected to start in the fourth quarter of 2016.
    • 30 Aug 2016 Planned initiation date changed from 1 Jan 2016 to 1 Oct 2016, as per Alcobra media release.
    • 19 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top